Physiology and Pharmacology
Physiol Pharmacol
Medical Sciences
http://ppj.phypha.ir
32
journal32
24765236
24765244
10.61186/phypha
(previous ISSN: 17350581)
en
jalali
1393
10
1
gregorian
2015
1
1
18
4
online
1
fulltext
en
اثر کندر روی مدل بیماری آلزایمر ناشی از تزریق داخل بطنی استرپتوزوتوسین
Effect of olibanum on a rat model of Alzheimer’s disease induced by intracerebroventricular injection of streptozotocin
Neurophysiology/Pharmacology
Neurophysiology/Pharmacology
Experimental research article
Experimental research article
Introduction: Olibanum improves memory in different models of learning. However, the effect of olibanum on
models of Alzheimer’s disease has been less studied. In the present study, the effect of olibanum on memory in normal
rats and in a rat model of Alzheimer disease induced by intracerebroventricular injections of streptozotocin was
evaluated.
Methods: Rats received an aqueous extract of olibanum (50, 100 and 300 mg/kg) via gavage, acutely 30 minutes
before the test and chronically for 21 consecutive days before assessment of memory racall. In two other groups of
animals, two guide cannulas were inserted into the lateral ventricles under stereotaxic surgery. One group received
bilateral injections of streptozotocin (1.5 mg/kg/2 μl/side) in the first and third days of surgery. The other group
received artificial cerebrospinal fluid. Fourteen days after surgery, learning was evaluated. Two other groups of animals
received olibanum (50 mg/kg) or its solvent, for 21 days beginning from one week before injections of streptozotocin.
Results: Acute administration of olibanum did not affect learning parameters, but chronic administration of it (50
mg/kg) improved memory retrieval. Streptozotocin increased number of necessary stimulations for induction of short
term memory, but decreased step through latency, significantly. In animals which received streptozotocin, olibanum
increased step through latency, significantly.
Conclusion: Olibanum reduces the risk of Alzheimer’s disease induced by streptozotocin. Further studies with
emphasis on active constituents of olibanum may result in development of drugs capable of decreasing probability of
Alzheimer’s disease occurrence.
Olibanum, Streptozotocin, Alzheimer disease
477
489
http://ppj.phypha.ir/browse.php?a_code=A-10-796-1&slc_lang=en&sid=1
Seyyed Rasoul
Zaker
سید رسول
ذاکر
srzaker@gmail.com
3200319475328460014960
3200319475328460014960
No
Division of Animal Sciences, Dept. of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran
Siamak
Beheshti
سیامک
بهشتی
siamak.beheshti@yahoo.com
3200319475328460014961
3200319475328460014961
Yes
Division of Animal Sciences, Dept. of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran
Rezvan
Aghaie
رضوان
آقائی
rezvans68@yahoo.com
3200319475328460014962
3200319475328460014962
No
Division of Animal Sciences, Dept. of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran
Maryam
Noorbakhshnia
مریم
نوربخش نیا
mnoorbakhshnia@yahoo.com
3200319475328460014963
3200319475328460014963
No
Division of Animal Sciences, Dept. of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran